---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-040724"
form_type: "8-K"
ticker: "ADIL"
cik: "0001513525"
company_name: "ADIAL PHARMACEUTICALS, INC."
filed_at: "2025-05-07T23:59:59+00:00"
generated_at: "2026-05-22T07:47:28.885699+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Adial raises $2.75M via warrant inducement; existing warrants exercised at $0.74

## Summary
- Existing Series B and C warrants for 3,718,440 shares exercised at reduced price of $0.74 per share.
- Company issued new unregistered Series B-1 (2.48M shares) and C-1 (4.03M shares) warrants at $0.74 exercise price.
- New warrants exercisable only after stockholder approval; Series B-1 expire in 5 years, C-1 in 18 months.
- Net proceeds to be used for working capital and general corporate purposes.

## SEC filing metadata
- accession: 0001213900-25-040724
- form_type: 8-K
- ticker: ADIL
- cik: 0001513525
- company_name: ADIAL PHARMACEUTICALS, INC.
- filed_at: 2025-05-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1513525/000121390025040724/0001213900-25-040724-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1513525/000121390025040724/ea0241155-8k_adial.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-040724
- JSON: https://secwatch.observer/filing/0001213900-25-040724.json
- Plain text: https://secwatch.observer/filing/0001213900-25-040724.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.